COURTNEY MCCLENDON: Open Payments
NPI 1962098384 · YATES CENTER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 16 payments from 7 companies in 2025. Trend: 2023 $297 · 2024 $369 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $131 |
| ABBVIE INC. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $14 |
Products named: COBENFY, CAPLYTA, VRAYLAR, Qelbree, REXULTI, ABILIFY MAINTENA, Auvelity, ARISTADA.
Industry payments across KS — which companies pay providers there.
